5-bromo-2-chloro-[1,3]thiazolo[5,4-b]pyridine;5-bromo-2-[(1S)-1-[1-[5-(trifluoromethyl)pyrimidin-2-yl]piperidin-4-yl]ethoxy]-[1,3]thiazolo[5,4-b]pyridine;(1R)-1-[1-[5-(trifluoromethyl)pyrimidin-2-yl]piperidin-4-yl]ethanol
C36H35Br2ClF6N10O2S2 — CID 160575432
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-bromo-2-chloro-[1,3]thiazolo[5,4-b]pyridine;5-bromo-2-[(1S)-1-[1-[5-(trifluoromethyl)pyrimidin-2-yl]piperidin-4-yl]ethoxy]-[1,3]thiazolo[5,4-b]pyridine;(1R)-1-[1-[5-(trifluoromethyl)pyrimidin-2-yl]piperidin-4-yl]ethanol
5-bromo-2-chloro-[1,3]thiazolo[5,4-b]pyridine;5-bromo-2-[(1S)-1-[1-[5-(trifluoromethyl)pyrimidin-2-yl]piperidin-4-yl]ethoxy]-[1,3]thiazolo[5,4-b]pyridine;(1R)-1-[1-[5-(trifluoromethyl)pyrimidin-2-yl]piperidin-4-yl]ethanol (PubChem CID 160575432) has the molecular formula C36H35Br2ClF6N10O2S2 and a molecular weight of 1013.13 g/mol. Its IUPAC name is 5-bromo-2-chloro-[1,3]thiazolo[5,4-b]pyridine;5-bromo-2-[(1S)-1-[1-[5-(trifluoromethyl)pyrimidin-2-yl]piperidin-4-yl]ethoxy]-[1,3]thiazolo[5,4-b]pyridine;(1R)-1-[1-[5-(trifluoromethyl)pyrimidin-2-yl]piperidin-4-yl]ethanol.
Molecular Properties
| Compound Name | 5-bromo-2-chloro-[1,3]thiazolo[5,4-b]pyridine;5-bromo-2-[(1S)-1-[1-[5-(trifluoromethyl)pyrimidin-2-yl]piperidin-4-yl]ethoxy]-[1,3]thiazolo[5,4-b]pyridine;(1R)-1-[1-[5-(trifluoromethyl)pyrimidin-2-yl]piperidin-4-yl]ethanol |
|---|---|
| PubChem CID | 160575432 |
| Molecular Formula | C36H35Br2ClF6N10O2S2 |
| Molecular Weight | 1013.13 g/mol |
| Exact Mass | 1010.03 |
| IUPAC Name | 5-bromo-2-chloro-[1,3]thiazolo[5,4-b]pyridine;5-bromo-2-[(1S)-1-[1-[5-(trifluoromethyl)pyrimidin-2-yl]piperidin-4-yl]ethoxy]-[1,3]thiazolo[5,4-b]pyridine;(1R)-1-[1-[5-(trifluoromethyl)pyrimidin-2-yl]piperidin-4-yl]ethanol |
| SMILES | C[C@@H](O)C1CCN(c2ncc(C(F)(F)F)cn2)CC1.C[C@H](Oc1nc2ccc(Br)nc2s1)C1CCN(c2ncc(C(F)(F)F)cn2)CC1.Clc1nc2ccc(Br)nc2s1 |
| InChI | InChI=1S/C18H17BrF3N5OS.C12H16F3N3O.C6H2BrClN2S/c1-10(28-17-25-13-2-3-14(19)26-15(13)29-17)11-4-6-27(7-5-11)16-23-8-12(9-24-16)18(20,21)22;1-8(19)9-2-4-18(5-3-9)11-16-6-10(7-17-11)12(13,14)15;7-4-2-1-3-5(10-4)11-6(8)9-3/h2-3,8-11H,4-7H2,1H3;6-9,19H,2-5H2,1H3;1-2H/t10-;8-;/m01./s1 |
| InChIKey | RBBWXBKVYQPPCN-TYYSFXPMSA-N |
| XLogP | 10.15 |
| TPSA | 139.06 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 14 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 59 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1013.13 |
| LogP ≤ 5 | 10.15 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 14 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 160575432 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.